MiMedx Comments on Proposed FDA Draft Guidance on Homologous Use of HCT/Ps
October 30, 2015 at 04:24 AM EDT
MiMedx Group, Inc. (NASDAQ: MDXG) commented on the proposed Draft Guidance on Homologous Use of Human Cells, Tissues, and Cellular and ...